Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance Assessment of Coronary Drug-Eluting Stent CRE8 : Post-market Observationnal Study

NCT03842813 is registered in ClinicalTrials.gov with Alvimedica Medical Technologies France as lead sponsor.

NCT NCT03842813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03842813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance Assessment of Coronary Drug-Eluting Stent CRE8 : Post-market Observationnal Study
Lead sponsor
Alvimedica Medical Technologies France
Phase
Observational
Overall status
Unknown status
Start date
April 9, 2019
Completion date
July 31, 2022
Enrollment
1,030 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

coronaropathy, diabetes